Please login to the form below

Not currently logged in
Email:
Password:

McCann Complete Medical expands into new Glasgow offices

Moves Complete Medical Communications and Complete HealthVizion employees to Skypark

The Skypark in the Finnieston area of Glasgow

The Skypark in the Finnieston area of Glasgow

McCann Complete Medical has moved its Glasgow-based employees into new offices in the city as its expands.

The group's Complete Medical Communications and Complete HealthVizion agencies, having swelled their ranks, have relocated their Glasgow operations to the Skypark, close to the city centre.

The 30 staff occupy two suites in Scotland's largest business development and McCann said the new location would be ideally suited to attract talent from the medical knowledge community in Glasgow and beyond.

Charlie Buckwell, McCann Complete Medical and Double Helix chief executive, said: “We are excited that two agencies in our group are moving their Glasgow offices to Skypark.

“As a growing healthcare communications business, we are delighted with the quality of the location, the scope for expansion and the access to a specialist medical knowledge talent pool."

The move is just the latest for McCann Complete Medical, whose 2014 expansion saw CMC move its US office to Hackensack (New Jersey) and Complete HealthVizion establish a new office base in Chicago.

Meanwhile, Caudex Medical expanded to larger offices in Manhattan and opened new offices in London and the group said 2015 is likely to see even further expansion and new locations open across the network in the UK and North America.

“Our objective is to stay close to clients and to access additional employment pools with specialist expertise and talent,” commented Charlie Buckwell.

14th January 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics